Hauck & Aufhäuser Privatbankiers KGaA reported on Gerresheimer (ETR:GXI), bumping up its stock price target to 80.00EUR today
- Updated: October 6, 2016
Just yesterday Gerresheimer (ETR:GXI) traded 0.00% even at 74.35EUR. The company’s 50-day moving average is 0.00EUR and its 200-day moving average is 0.00EUR. The last stock close price is up 0.00% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 0 shares of the stock were exchanged, down from an average trading volume of 0
Hauck & Aufhäuser Privatbankiers KGaA upped the price target of Gerresheimer (ETR:GXI) to 80.00EUR reporting a possible upside of 0.08%.
Previously on 10/06/2016, Hauck & Aufhäuser Privatbankiers KGaA released a statement about Gerresheimer (ETR:GXI) increased the target price from 0.00EUR to 80.00EUR. At the time, this indicated a possible upside of 0.08%.
See Chart Below
Gerresheimer has a with a one year low of 0.00EUR and a one year high of 0.00EUR The company’s market capitalization is currently 0 EUR.
Brief Synopsis On Gerresheimer (ETR:GXI)
Gerresheimer AG is a Germany-based company that operates in the pharmaceuticals and health care industry. It is structured in three business segments: Plastic and Devices, Primary Packaging Glass and Life Science Research. The Company produces pharmaceutical packaging products, as well as drug-delivery systems made out of glass and plastics or a combination of both. Its product portfolio includes insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.